Evaluate FATE stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in FATE? | Glauxie AI

Q: What are the risks of investing in FATE?

Fate Therapeutics, Inc. (FATE) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Bahram Valamehr. Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology... Employees: 161.

Q: How much debt does FATE have?

Review FATE total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is FATE a good long-term investment?

Evaluate FATE as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in FATE?

🦉

Fate Therapeutics, Inc. (FATE)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOBahram Valamehr

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma,...

Key Executives

Name	Title
Andrew Henry	Senior Vice President of Clinical Operations
Bahram Valamehr	President, Chief Executive Officer & Director
Cindy R. Tahl	Chief Legal & Compliance Officer and Corporate Secretary
Jessica Francis	Senior Vice President of Human Resources & Operations
Kamal Adawi	CFO & Treasurer
Kate Duvall	Corporate Controller

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

FATE Profile Financials

Is FATE stock safe? How much debt does FATE have? Is FATE a good long-term investment?